Skip to main content
Top
Published in: Quality of Life Research 8/2017

Open Access 01-08-2017

Symptom burden and life challenges reported by adult chordoma patients and their caregivers

Authors: Paula H. Song, Hadi Beyhaghi, Josh Sommer, Antonia V. Bennett

Published in: Quality of Life Research | Issue 8/2017

Login to get access

Abstract

Purpose

This study aims to characterize the symptom burden and life challenges that chordoma patients and their caregivers experience.

Methods

In this cross-sectional study, we analyzed data from the Chordoma Foundation online community survey conducted in 2014. Frequency counts and percentages were calculated to determine the prevalence of self-reported symptoms and life challenges in the sample. We used Fisher’s exact test to compare self-reported symptoms among subgroups with different disease status, tumor locations, and treatments received.

Results

Among the survey participants, 358 identified themselves as chordoma patients and 202 as caregivers. The majority of the patients were over 45 years (72%), male (56%), educated beyond high school degree (87%), and from North America (77%). Skull base was the most prevalent tumor location (40%). Chronic pain (35%) was the most commonly reported symptom followed by depression or severe anxiety (32%) and chronic fatigue (31%). Among patients, the most commonly reported challenges included delayed care (37%), long-term disability (33%), and confusion or unanswered questions about chordoma (28%). For caregivers, grief (55%), delayed diagnosis (47%), and difficulty helping the patient cope with his or her disease (45%) were most common.

Conclusions

Our study findings suggest a high symptom burden and life challenges among chordoma patients and their caregivers. This study provides preliminary, limited estimates of the prevalence of a wide range of self-reported symptoms and challenges that will inform the assessment of patient-reported outcomes in future clinical trials and help clinicians better manage chordoma patients’ symptoms.
Appendix
Available only for authorised users
Literature
1.
go back to reference Walcott, B. P., Nahed, B. V., Mohyeldin, A., Coumans, J. V., Kahle, K. T., & Ferreira, M. J. (2012). Chordoma: Current concepts, management, and future directions. The Lancet Oncology, 13(2), e69–e76.CrossRefPubMed Walcott, B. P., Nahed, B. V., Mohyeldin, A., Coumans, J. V., Kahle, K. T., & Ferreira, M. J. (2012). Chordoma: Current concepts, management, and future directions. The Lancet Oncology, 13(2), e69–e76.CrossRefPubMed
2.
go back to reference Diaz, R. J., Maggacis, N., Zhang, S., & Cusimano, M. D. (2014). Determinants of quality of life in patients with skull base chordoma: Clinical article. Journal of Neurosurgery, 120(2), 528–537.CrossRefPubMed Diaz, R. J., Maggacis, N., Zhang, S., & Cusimano, M. D. (2014). Determinants of quality of life in patients with skull base chordoma: Clinical article. Journal of Neurosurgery, 120(2), 528–537.CrossRefPubMed
3.
go back to reference Chambers, K. J., Lin, D. T., Meier, J., Remenschneider, A., Herr, M., & Gray, S. T. (2014). Incidence and survival patterns of cranial chordoma in the United States. The Laryngoscope, 124(5), 1097–1102.CrossRefPubMed Chambers, K. J., Lin, D. T., Meier, J., Remenschneider, A., Herr, M., & Gray, S. T. (2014). Incidence and survival patterns of cranial chordoma in the United States. The Laryngoscope, 124(5), 1097–1102.CrossRefPubMed
4.
go back to reference Smoll, N. R., Gautschi, O. P., Radovanovic, I., Schaller, K., & Weber, D. C. (2013). Incidence and relative survival of chordomas. Cancer, 119(11), 2029–2037.CrossRefPubMed Smoll, N. R., Gautschi, O. P., Radovanovic, I., Schaller, K., & Weber, D. C. (2013). Incidence and relative survival of chordomas. Cancer, 119(11), 2029–2037.CrossRefPubMed
5.
go back to reference McMaster, M. L., Goldstein, A. M., Bromley, C. M., Ishibe, N., & Parry, D. M. (2001). Chordoma: Incidence and survival patterns in the United States, 1973–1995. Cancer Causes & Control, 12(1), 1–11.CrossRef McMaster, M. L., Goldstein, A. M., Bromley, C. M., Ishibe, N., & Parry, D. M. (2001). Chordoma: Incidence and survival patterns in the United States, 1973–1995. Cancer Causes & Control, 12(1), 1–11.CrossRef
6.
go back to reference Lee, J., Bhatia, N. N., Hoang, B. H., Ziogas, A., & Zell, J. A. (2012). Analysis of prognostic factors for patients with chordoma with use of the California Cancer Registry. The Journal of Bone and Joint Surgery. American volume, 94(4), 356–363.CrossRefPubMed Lee, J., Bhatia, N. N., Hoang, B. H., Ziogas, A., & Zell, J. A. (2012). Analysis of prognostic factors for patients with chordoma with use of the California Cancer Registry. The Journal of Bone and Joint Surgery. American volume, 94(4), 356–363.CrossRefPubMed
7.
go back to reference Gil, Z., & Fliss, D. M. (2010). Quality of life in patients with skull base tumors: current status and future challenges. Skull Base, 20(01), 011–018.CrossRef Gil, Z., & Fliss, D. M. (2010). Quality of life in patients with skull base tumors: current status and future challenges. Skull Base, 20(01), 011–018.CrossRef
8.
go back to reference Stacchiotti, S., & Sommer, J. (2015). Building a global consensus approach to chordoma: A position paper from the medical and patient community. The Lancet Oncology, 16(2), e71–e83.CrossRefPubMed Stacchiotti, S., & Sommer, J. (2015). Building a global consensus approach to chordoma: A position paper from the medical and patient community. The Lancet Oncology, 16(2), e71–e83.CrossRefPubMed
9.
go back to reference Gnanasakthy, A., DeMuro, C., Clark, M., Haydysch, E., Ma, E., & Bonthapally, V. (2016). patient-reported outcomes labeling for products approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010–2014). Journal of Clinical Oncology, 34, 1928–1934.CrossRefPubMed Gnanasakthy, A., DeMuro, C., Clark, M., Haydysch, E., Ma, E., & Bonthapally, V. (2016). patient-reported outcomes labeling for products approved by the Office of Hematology and Oncology Products of the US Food and Drug Administration (2010–2014). Journal of Clinical Oncology, 34, 1928–1934.CrossRefPubMed
10.
go back to reference Basch, E., & Bennett, A. V. (2014). Patient-reported outcomes in clinical trials of rare diseases. Journal of General Internal Medicine, 29(3), 801–803.CrossRefPubMedCentral Basch, E., & Bennett, A. V. (2014). Patient-reported outcomes in clinical trials of rare diseases. Journal of General Internal Medicine, 29(3), 801–803.CrossRefPubMedCentral
11.
go back to reference Food and Drug Administration (2009). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Federal Register, 74, 65132–65133. Food and Drug Administration (2009). Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. Federal Register, 74, 65132–65133.
12.
go back to reference Sneeuw, K. C., Sprangers, M. A., & Aaronson, N. K. (2002). The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. Journal of Clinical Epidemiology, 55(11), 1130–1143.CrossRefPubMed Sneeuw, K. C., Sprangers, M. A., & Aaronson, N. K. (2002). The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. Journal of Clinical Epidemiology, 55(11), 1130–1143.CrossRefPubMed
13.
go back to reference Srivastava, A., Vischioni, B., Fiore, M. R., Vitolo, V., Fossati, P., Iannalfi, A., ... & Orecchia, R. (2013). Quality of life in patients with chordomas/chondrosarcomas during treatment with proton beam therapy. Journal of Radiation Research, 54(suppl 1), i43–i48.CrossRefPubMedPubMedCentral Srivastava, A., Vischioni, B., Fiore, M. R., Vitolo, V., Fossati, P., Iannalfi, A., ... & Orecchia, R. (2013). Quality of life in patients with chordomas/chondrosarcomas during treatment with proton beam therapy. Journal of Radiation Research, 54(suppl 1), i43–i48.CrossRefPubMedPubMedCentral
14.
go back to reference van Wulfften Palthe, O. D., Janssen, S. J., Wunder, J. S., Ferguson, P. C., Wei, G., Rose, P. S., ... & Hornicek, F. J., et al. (2016). What questionnaires to use when measuring quality of life in sacral tumor patients: The updated sacral tumor survey. The Spine Journal. van Wulfften Palthe, O. D., Janssen, S. J., Wunder, J. S., Ferguson, P. C., Wei, G., Rose, P. S., ... & Hornicek, F. J., et al. (2016). What questionnaires to use when measuring quality of life in sacral tumor patients: The updated sacral tumor survey. The Spine Journal.
Metadata
Title
Symptom burden and life challenges reported by adult chordoma patients and their caregivers
Authors
Paula H. Song
Hadi Beyhaghi
Josh Sommer
Antonia V. Bennett
Publication date
01-08-2017
Publisher
Springer International Publishing
Published in
Quality of Life Research / Issue 8/2017
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-017-1544-2

Other articles of this Issue 8/2017

Quality of Life Research 8/2017 Go to the issue